Dr David Guttery

Contact Details

Photo of Dr David GutteryLeicester Cancer Research Centre
College of Life Sciences
University of Leicester
Room 425, Level 4,
Robert Kilpatrick Clinical Sciences Building
Leicester Royal Infirmary
PO BOX 65, Leicester LE2 7LX, United Kingdom

Tel: +44 (0)116 252 3181
Email: dsg6@le.ac.uk

Current Position(s)

Lecturer in Early Cancer Detection
Postgraduate Tutor for Leicester Cancer Research Centre
AccessAbility Tutor for Genetics and Genome Biology

Awards/Positions of Esteem

Steering Committee Member – ECMC Junior Investigator Networking Group (JING)
Higher Education Academy - Fellow
Member – European Network for Individualised Treatment in Endometrial Cancer (ENITEC)

Professional Registrations

Member - British Association for Cancer Research (BACR)

Somatic mutation and copy number variation diagramResearch Interests

My research interests are focused on combining artificial intelligence with liquid biopsies towards personalised therapeutic strategies and earlier detection and monitoring of cancer relapse. Our research has been pioneering in development and utilisation of next-generation sequencing methods for early detection and monitoring of cancer. Our research was among the first to highlight the importance of copy number aberrations AND somatic mutations in cfDNA for real-time monitoring of tumour evolution and acquired resistance to aromatase inhibitors by next-generation sequencing (A), as well as showing that cfDNA profiles can deconvolute the heterogeneity observed in single circulating tumour cells (B).

Current areas of research:

Earlier detection of acquired resistance in metastatic breast cancer using ctDNA
In collaboration with Professor Jacqui Shaw:

  • Utility of ctDNA methylation for earlier detection of impending resistance in patients with metastatic breast cancer.
  • Inferring gene expression through nucleosome occupancy in ctDNA to highlight key genes involved in acquired resistance to hormone therapies.

Utility of ctDNA for earlier detection of relapse and progression in endometrial cancer

Gynaecology research group lead by Dr Esther Moss.  I lead laboratory parts of:

  • Microsatellite loci - GutteryDetection of impending relapse or progression earlier than PET/CT scans or clinical examination through personalised NGS of ctDNA
  • Analysis of microsatellite instability in ctDNA for stratification of patients towards immunotherapies
  • Elucidating differences in mutational profiles of endometrial cancer patients based on ethnicity
  • Deconvolution of immune cell infiltration for improved therapeutic stratification using NGS.

Artificial intelligence for improved cancer diagnosis, individualised patient therapies and prediction of relapse

In collaboration with Professor Yudong Zhang:

  • Using state of the art deep neural networks for improving cancer detection in mammograms
  • Prediction of cancer molecular subtype and clinically actionable mutations using diagnostic slides
  • Prognostication of cancer patients at high-risk of relapse using diagnostic slides to improve therapeutic strategies
  • Combining state of the art deep neural networks with ctDNA for improved treatment regimens and monitoring of patients of follow-up.

Key Collaborations

Professor Jacqui Shaw
Dr Esther Moss
Professor Yu-Dong Zhang


1999-2003: BSc (Hons) in Medicinal Biochemistry, University of Wolverhampton
2004-2005: MSc in Molecular Pathology and Toxicology, University of Leicester
2005-2008: PhD in Molecular Breast Pathology, University of Leicester
2008-2009: Post-Doctoral Scientist - MRC Toxicology Unit, University of Leicester
2009-2010: Research Associate - Dept. of Cancer Studies and Molecular Medicine, University of Leicester
2010-2012: Research Fellow - Centre for Genetics and Genomics, University of Nottingham
2012-2017: Senior Research Associate – Dept. of Cancer Studies, University of Leicester
2017-present: Lecturer in Cancer Early Detection - Leicester Cancer Research Centre, University of Leicester
2018 -present: Postgraduate Tutor - Leicester Cancer Research Centre, University of Leicester
2019 - present: Fellow of the Higher Education Academy


You can view my publications here.

Google Scholar


MSc Cancer Molecular Pathology and Therapeutics - Co-Course Convenor
BS3031 - Human Genetics
BS3003 - Cancer Cell and Molecular Biology
MB1080 - Introduction to Medical Sciences

Current PhD Supervision

1st Supervisor

  • Diviya Gorsia - Leicester Precision Medicine Institute/CLS/Hope Against Cancer studentship (2nd Supervisor: Dr Esther Moss)
  • Areej Alahmari - Funded by Government of Saudi Arabia (2nd Supervisor: Professor Jacqui Shaw)
  • Bethany Woodvine - MIBTP funded (2nd Supervisor: Professor Catrin Pritchard)

2nd Supervisor

  • Tumisang Ntereke - Funded by the Botswana High Commission (1st Supervisor: Professor Jacqui Shaw)
  • Qi Guo - Self-funded (1st Supervisor: Professor Jacqui Shaw)
  • Samantha Sinnadurai - Funded by College of Life Sciences (1st Supervisor: Professor Catrin Pritchard)
  • Cheng Kang - Self-funded (1st Supervisor: Professor Yu-Dong Zhang)

Share this page:


Powerful pre-clinical platform for anti-cancer drug and biomarker discovery

Pre-clinical models that can accurately predict outcomes in the clinic are much sort after in the field of cancer drug discovery and development.  Read about how patient derived explants offer many advantages and are the powerful model of choice. A copy of the review, published in the British Journal of Cancer, is available by clicking this link: PDE Platform


SEND Study Success

Congratulations to Chris Avery, who with collaborating colleagues published findings of the SEND study, a multi-centre randomised trial using two different surgical protocols for mouth cancer treatment.  A nationwide first for this type of trial, using real-world data.  The paper, published in the British Journal of Cancer, is available by clicking this link: SEND Paper


Centre Health and Wellbeing Group
Join up for a walk on the park Friday lunchtime - details here.

More information from Jenny McNair jm65@le.ac.uk

Contact Details

Leicester Cancer Research Centre
Robert Kilpatrick Clinical Sciences Building
University of Leicester
Leicester Royal Infirmary
Leicester LE2 7LX

T: +44 (0) 116 252 3170
E: cancerstudies@le.ac.uk

(Please note this email address should not be used for clinical referrals or patient correspondence)

Maps and Directions

Sat Nav users: 


AccessAble logo

The University of Leicester is committed to equal access to our facilities. DisabledGo has a detailed accessibility guide for the Robert Kilpatrick Clinical Sciences Building.